Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Ms Indranee was speaking on a motion expressing regret at Mr Singh’s conduct. Read more at straitstimes.com. Read more at ...
Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...
With that as the backdrop, here's a rundown of three dividend stocks to buy with plans to only hold them for the next 10 ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
Merck is in talks to buy cancer drug developer Revolution Medicines, the Financial Times reported on Thursday, citing people ...
SALEM: With sugar mills across Tamil Nadu commencing their crushing season, farmers are pressing the state government to ...
Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
Merck (MRK) is back in focus after a trio of recent developments, including an upcoming J.P. Morgan Healthcare Conference ...
This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Cyber Monday and Black Friday are a thing of the ...
This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Top tech, kitchen appliances, outdoor gear, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback